Abstract
According to data on the imidazole antimycotics at present on the market, none of these products satisfactorily fills the gaps which exist in the treatment for mycoses of internal organs, although they have brought considerable progress in the topical treatment of mycoses. On the basis of their very broad spectrum and high intensity of activity under suitable test conditions, and the comparatively tolerable amount of side effects in man, the present imidazole antimycotics are considered to be an encouraging start for future development of derivatives which will lead to products with considerably better pharmacokinetic, and therefore better therapeutic, properties.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Deresinski S. C., Lilly R. B., Levine H. B., Galgiani J. N., Stevens D. A. Treatment of fungal meningitis with miconazole. Arch Intern Med. 1977 Sep;137(9):1180–1185. [PubMed] [Google Scholar]
- Drouhet E. Antifungal agents. Antibiot Chemother (1971) 1978;25:253–288. doi: 10.1159/000401066. [DOI] [PubMed] [Google Scholar]
- Negroni R., Rubinstein P., Herrmann A., Gimenez A. Results of miconazole therapy in twenty-eight patients with paracoccidioidomycosis (South American blastomycosis). Proc R Soc Med. 1977;70 (Suppl 1):24–28. doi: 10.1177/00359157770700S108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stevens D. A., Levine H. B., Deresinski S. C. Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man. Am J Med. 1976 Feb;60(2):191–202. doi: 10.1016/0002-9343(76)90428-9. [DOI] [PubMed] [Google Scholar]
- Sung J. P., Grendahl J. G., Levine H. B. Intravenous and intrathecal miconazole therapy for systemic mycoses. West J Med. 1977 Jan;126(1):5–13. [PMC free article] [PubMed] [Google Scholar]